URS
TXG icon

Utah Retirement Systems’s 10x Genomics TXG Stock Holding History

Utah Retirement Systems’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,100
Closed -$285K – 988
2023
Q4 		$285K Buy
5,100
+100
+2% +$4.35K ﹤0.01% 877
2023
Q3 		$206K Sell
5,000
-16,901
-77% -$879K ﹤0.01% 937
2023
Q2 		$1.22M Sell
21,901
-600
-3% -$32.5K 0.02% 690
2023
Q1 		$1.26M Buy
22,501
+2,793
+14% +$130K 0.02% 680
2022
Q4 		$718K Hold
19,708
– – 0.01% 762
2022
Q3 		$561K Buy
19,708
+100
+0.5% +$3.81K 0.01% 798
2022
Q2 		$888K Buy
19,608
+2,588
+15% +$134K 0.01% 730
2022
Q1 		$1.29M Buy
17,020
+1,894
+13% +$166K 0.02% 692
2021
Q4 		$2.25M Buy
15,126
+1,163
+8% +$178K 0.03% 540
2021
Q3 		$2.03M Buy
13,963
+100
+0.7% +$17.2K 0.03% 561
2021
Q2 		$2.71M Buy
13,863
+2,763
+25% +$500K 0.03% 485
2021
Q1 		$2.01M Buy
11,100
+8,100
+270% +$1.4M 0.03% 564
2020
Q4 		$425K Buy
3,000
+500
+20% +$72.6K 0.01% 835
2020
Q3 		$312K Buy
2,500
+200
+9% +$21K 0.01% 856
2020
Q2 		$205K Buy
+2,300
New +$179K ﹤0.01% 942

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Utah Retirement Systems's TXG Position: Q1 2024 in Review

Utah Retirement Systems sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 5,100 shares — an estimated $285K sold.

Utah Retirement Systems first reported a position in TXG in Q2 2020 and held it in 15 quarters. The position peaked at $2.71M in Q2 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Utah Retirement Systems reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Utah Retirement Systems sold 5,100 10x Genomics shares in Q1 2024, an estimated $285K.
  • Utah Retirement Systems first reported a position in 10x Genomics in Q2 2020 and held it in 15 quarters.
  • Utah Retirement Systems's 10x Genomics position peaked at $2.71M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Utah Retirement Systems's 13F filing for Q1 2024, filed 15 May 2024.